Bank of America resets Hims and Hers stock price target
Hims & Hers has been one of the most closely watched names in digital health this month. Between the FDA’s peptide announcement, a Novo Nordisk settlement, and a flood of analyst revisions, the stock has barely had a moment to breathe. Now Bank of America has weighed in again. And the reason behind this latest […]
Bank of America resets Hims and Hers stock price target Read More »
